With regard to South Korea, Novartis fixed selected effectively-publicized allegations that it had made poor payments to HCPs in South Korea through spherical tables and 3rd-bash healthcare journals. Novartis Korea allegedly transmitted improper honoraria to HCPs for spherical tables by way of healthcare journals to stop compliance scrutiny, and en